Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 2021

View Archived Issues

Platelets release antigenic DNA in lupus

Intracranial samples give glimpse into stroke response

New phase II trial evaluates BIVV-020 in chronic inflammatory demyelinating polyneuropathy

Janssen opens phase III study of rilematovir in neonates, infants and children with RSV infection

Enrollment opens in phase II study of maralixibat for infants with biliary atresia

Phase III trial of Otividex for Meniere's disease does not meet primary endpoint

Aridis announces new inhaled antibody for COVID-19

Enrollment completed in phase II study of SSS-06 long-acting erythropoietin-stimulating protein

Pelareorep plus CAR T-cell therapy show synergistic activity in preclinical models of solid tumors

Carragelose lozenges show promising activity against respiratory viruses including SARS-CoV-2

Heparegenix patents MAP2K4 inhibitors

Shenzhen Chipscreen Biosciences identifies new THR beta agonists

Integral BioSciences divulges Chk1 inhibitors

Medshine Discovery synthesizes PARP-1 inhibitors

New PTPN11 inhibitors presented by Etern Biopharma

Salarius initiates expansion stage for phase I/II study of seclidemstat in Ewing sarcoma

Longeveron completes phase I study of Lomecel-B in hypoplastic left heart syndrome

Benitec reports interim data on pilot dosing study of BB-301 for OPMD

Constant Therapeutics initiates phase II study of TXA-27 in patients with COVID-19 in Israel

Novel model of age-related hearing loss with consistent flat cochlear epithelium phenotype

New model developed for testing drugs for Nav1.9-related neuropathic pain

Decibel Therapeutics presents DB-OTO for genetic hearing loss

Generex reports data on Ii-Key-SARS-CoV-2 vaccine in transgenic mouse model

Bacterial protease takes on "undruggable" oncoprotein

Insilico Medicine announces preclinical candidate for IPF

Locus Biosciences completes phase Ib study of LBP-EC01 bacteriophage therapy

Phase IIb interim data on mirdametinib in NF1-associated plexiform neurofibromas

Pfizer and BioNTech begin evaluation of third dose of COVID-19 vaccine

FDA approves Humira for pediatric patients with ulcerative colitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...